Therapeutics
- FUNDINGFUNDING · 1 min
Scribe Therapeutics raises $128.7 million in upsized IPO, shares jump 67%
Scribe Therapeutics, a clinical-stage gene therapy developer focused on heart diseases, raised $128.7 million in an upsized initial public offering on Thursday.
24 Jul, 11:28 pm IST - STARTUPSSTARTUPS · 2 min
Immuneel Therapeutics raises ₹100 crore to expand gene therapy for blood cancer
Immuneel Therapeutics, a Bengaluru-based biotech startup, raised ₹100 crore in a Series B funding round led by Singularity AMC and Rainmatter by Zerodha, w…
08 Jun, 02:08 pm IST